이 기사의 번역을 준비하고 있습니다. 그동안 영어 원문을 임시로 표시합니다.
비즈니스 · 2015. 6. 3.1 분 읽기
Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Disclosure Regarding Additional Risks in Direct-to-Consumer Prescription Drug Television Advertisements
로컬 자동 번역 · 원본 출처 언어
요약
The Food and Drug Administration (FDA) is announcing that a collection of information entitled, "Disclosure Regarding Additional Risks in Direct-to-Consumer Prescription Drug Television Advertisements" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
원본 출처 언어: Federal Register — Food and Drug Administration원문 발표 열기 →